Film critic Peter Travers reviews "Companion," written and directed by Drew Hancock, starring Sophie Thatcher and Jack Quaid.

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Kaeberlein is co-director of the Dog Aging Project, an ambitious research effort to track the aging process of tens of thousands of companion dogs across the US. He is one of a handful of scientists ...

Police continued their search for the suspect Wednesday night. Judge blocks Trump executive order to end birthright ...

Four people, including a minor, were arrested for stealing 30 mobile phones during the Dinagyang Festival celebration here on ...

ABC 10News anchor Lindsey Pena stops by Hilliker's Ranch Fresh Eggs in Lakeside to learn more about the reasons behind the ...

As recent advances in small molecules, ADCs, cell, and gene therapies poise novel precision therapies from the bench to the clinic, the 15th World Clinical Biomarkers & Companion Diagnostics Summit ...

A quarter of a century later, precisely and recently, the boy and the father returned to Yosemite Falls to try and relive that Squeezit red red-letter day. En route, poet William Wordsworth’s worthy ...

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY ...

As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...

A House committee will hold a hearing this week scrutinizing whether National Institutes of Health animal research amounts to ...